RIA Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

RIA Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,436	Closed	-$433K	–	144
2023 Q4	$433K	Sell	8,436 -706	-8%	-$37.1K	0.18%	66
2023 Q3	$531K	Sell	9,142 -675	-7%	-$41.4K	0.24%	56
2023 Q2	$628K	Buy	9,817 +3,123	+47%	+$209K	0.27%	58
2023 Q1	$464K	Sell	6,694 -118	-2%	-$8.32K	0.21%	69
2022 Q4	$490K	Buy	+6,812	New	+$514K	0.28%	55

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RIA Advisory Group's BMY Position: Q1 2024 in Review

RIA Advisory Group sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 8,436 shares — an estimated $433K sold.

RIA Advisory Group first reported a position in BMY in Q4 2022 and held it in 5 quarters. The position peaked at $628K in Q2 2023. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

RIA Advisory Group reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
RIA Advisory Group sold 8,436 Bristol-Myers Squibb shares in Q1 2024, an estimated $433K.
RIA Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 5 quarters.
RIA Advisory Group's Bristol-Myers Squibb position peaked at $628K in Q2 2023.
2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on RIA Advisory Group's 13F filing for Q1 2024, filed 3 May 2024.